Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls.

Petrovsky N, Ettinger U, Quednow BB, Landsberg MW, Drees J, Lennertz L, Frommann I, Heilmann K, Sträter B, Kessler H, Dahmen N, Mössner R, Maier W, Wagner M.

Int J Neuropsychopharmacol. 2013 Aug;16(7):1473-81. doi: 10.1017/S1461145713000011. Epub 2013 Feb 11.

PMID:
23399382
2.

Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison.

Rycroft N, Hutton SB, Clowry O, Groomsbridge C, Sierakowski A, Rusted JM.

Psychopharmacology (Berl). 2007 Dec;195(2):245-53. Epub 2007 Aug 5.

PMID:
17676402
3.

Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy.

Petrovsky N, Ettinger U, Quednow BB, Walter H, Schnell K, Kessler H, Mössner R, Maier W, Wagner M.

Psychopharmacology (Berl). 2012 May;221(1):27-38. doi: 10.1007/s00213-011-2540-9. Epub 2011 Oct 29.

PMID:
22038536
4.

The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine.

Rycroft N, Hutton SB, Rusted JM.

Psychopharmacology (Berl). 2006 Nov;188(4):521-9. Epub 2006 Aug 1.

PMID:
16896958
5.

Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.

Knott VJ, Millar AM, McIntosh JF, Shah DK, Fisher DJ, Blais CM, Ilivitsky V, Horn E.

Biol Psychol. 2011 Sep;88(1):83-93. doi: 10.1016/j.biopsycho.2011.06.012. Epub 2011 Jul 13.

PMID:
21742012
6.

Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.

Grundey J, Amu R, Ambrus GG, Batsikadze G, Paulus W, Nitsche MA.

Psychopharmacology (Berl). 2015 Jul;232(14):2491-501. doi: 10.1007/s00213-015-3880-7. Epub 2015 Feb 27.

PMID:
25721074
7.

Effects of procyclidine on eye movements in schizophrenia.

Ettinger U, Kumari V, Zachariah E, Galea A, Crawford TJ, Corr PJ, Taylor D, Das M, Sharma T.

Neuropsychopharmacology. 2003 Dec;28(12):2199-208.

8.

The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.

Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE.

Neuropsychopharmacology. 2008 Feb;33(3):480-90. Epub 2007 Apr 18.

9.

Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status.

Rabin RA, Sacco KA, George TP.

Schizophr Res. 2009 Oct;114(1-3):91-7. doi: 10.1016/j.schres.2009.07.006. Epub 2009 Aug 4.

10.

Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia.

Hong LE, Schroeder M, Ross TJ, Buchholz B, Salmeron BJ, Wonodi I, Thaker GK, Stein EA.

Schizophr Bull. 2011 Mar;37(2):416-25. doi: 10.1093/schbul/sbp089. Epub 2009 Aug 27.

11.

Effect of nicotine on saccadic eye movement latencies in non-smokers.

Bowling AC, Donnelly JF.

Hum Psychopharmacol. 2010 Jul;25(5):410-8. doi: 10.1002/hup.1134.

PMID:
20589920
12.

A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning.

Dawkins L, Powell JH, West R, Powell J, Pickering A.

Psychopharmacology (Berl). 2007 Mar;190(4):457-67. Epub 2007 Jan 5.

PMID:
17205318
13.

Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.

Drusch K, Lowe A, Fisahn K, Brinkmeyer J, Musso F, Mobascher A, Warbrick T, Shah J, Ohmann C, Winterer G, Wölwer W.

Eur Arch Psychiatry Clin Neurosci. 2013 Sep;263(6):519-27. doi: 10.1007/s00406-012-0377-9. Epub 2012 Oct 19.

PMID:
23081705
14.

Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.

Poltavski DV, Petros T.

Physiol Behav. 2006 Mar 30;87(3):614-24. Epub 2006 Feb 7.

PMID:
16466655
15.

Effects of the nicotine patch on performance during the first week of smoking cessation.

Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC.

Nicotine Tob Res. 2003 Apr;5(2):169-80. Review.

PMID:
12745489
16.

The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?

Quisenaerts C, Morrens M, Hulstijn W, de Bruijn E, Timmers M, Streffer J, De la Asuncion J, Dumont G, Sabbe B.

Psychopharmacology (Berl). 2014 Feb;231(3):543-50.

PMID:
24022237
17.

Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.

Allen MH, Debanné M, Lazignac C, Adam E, Dickinson LM, Damsa C.

Am J Psychiatry. 2011 Apr;168(4):395-9. doi: 10.1176/appi.ajp.2010.10040569. Epub 2011 Jan 18.

PMID:
21245085
18.

Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.

Poltavski DV, Petros T.

Physiol Behav. 2005 Jan 17;83(5):833-43. Epub 2004 Nov 23.

PMID:
15639169
19.

Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.

Jubelt LE, Barr RS, Goff DC, Logvinenko T, Weiss AP, Evins AE.

Psychopharmacology (Berl). 2008 Jul;199(1):89-98. doi: 10.1007/s00213-008-1133-8. Epub 2008 Jun 12.

Supplemental Content

Support Center